CN Stock MarketDetailed Quotes

002755 Beijing Aosaikang Pharmaceutical

Watchlist
  • 13.31
  • +0.46+3.58%
Not Open Oct 15 15:00 CST
12.35BMarket Cap144.67P/E (TTM)

Beijing Aosaikang Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
57.06%1.03B
56.11%1.17B
35.50%1.05B
-1.27%822.59M
-11.13%658.17M
-14.20%747.52M
-33.70%772.71M
-1.55%833.14M
-13.28%740.59M
5.98%871.26M
Transactional financial assets
10.15%917.81M
-5.22%727.62M
-14.93%713.83M
-1.00%868.41M
-8.99%833.24M
-6.34%767.66M
60.62%839.08M
78.01%877.17M
64.07%915.58M
27.07%819.61M
Notes receivable and accounts receivable
16.59%214.45M
-17.55%139.79M
-33.76%141.32M
-36.86%188.69M
-47.35%183.93M
-56.11%169.54M
-57.04%213.36M
-42.43%298.87M
-42.14%349.31M
-43.35%386.25M
-Notes receivable
----
----
----
----
----
----
182.95%2.03M
----
----
--1.98M
-Accounts receivable
16.59%214.45M
-17.55%139.79M
-33.13%141.32M
-36.86%188.69M
-47.35%183.93M
-55.88%169.54M
-57.38%211.33M
-42.43%298.87M
-41.68%349.31M
-43.64%384.27M
Other receivables (including interest and dividends)
-37.31%14.39M
-42.17%13.59M
97.88%49.88M
-38.34%16.47M
13.82%22.96M
41.77%23.49M
54.74%25.21M
-73.86%26.71M
17.97%20.17M
-2.94%16.57M
-Dividend receivable
----
----
233.33%1.56M
----
----
----
--467.8K
----
----
----
-Other receivable
-37.31%14.39M
----
95.32%48.32M
----
13.82%22.96M
----
51.87%24.74M
----
17.97%20.17M
----
Advance payment
-27.70%9.8M
-57.88%20.59M
57.15%14.84M
-70.45%15.23M
-90.10%13.56M
-11.45%48.89M
-39.55%9.44M
-77.78%51.54M
198.53%137.01M
30.67%55.21M
Inventories
17.57%181.59M
7.10%170.05M
18.34%167.49M
11.36%156.99M
-3.45%154.45M
13.58%158.78M
-0.22%141.53M
-4.36%140.98M
8.26%159.98M
-12.33%139.8M
Receivable financing
-13.16%52.87M
-45.81%73.62M
-63.60%39.92M
-34.29%54.54M
-38.48%60.88M
13.06%135.85M
28.66%109.67M
-31.30%83M
-18.00%98.96M
-57.10%120.16M
Other current assets
-55.99%11.88M
-60.24%13.11M
-55.16%12.16M
25.94%25.19M
87.62%27M
-24.10%32.98M
-37.69%27.12M
70.03%20M
-14.78%14.39M
356.52%43.45M
Total current assets
24.68%2.44B
11.54%2.33B
2.26%2.19B
-7.86%2.15B
-19.78%1.95B
-14.99%2.08B
-14.03%2.14B
-5.70%2.33B
3.04%2.44B
-7.71%2.45B
Non Current assets
Other equity investment
239.37%13.68M
260.23%13.67M
259.37%13.69M
262.12%13.99M
14.24%4.03M
9.07%3.79M
14.40%3.81M
5.22%3.86M
-7.97%3.53M
-9.89%3.48M
Investment real estate
-5.17%39M
-5.10%39.53M
-5.04%40.06M
3,033.67%40.59M
3,005.48%41.12M
2,978.50%41.65M
2,952.64%42.18M
-8.18%1.3M
-8.02%1.32M
-7.86%1.35M
Long-term equity investment
-0.80%104.12M
-0.30%103.89M
0.73%104.52M
2.70%105M
3.02%104.96M
2.93%104.2M
1.88%103.76M
6.31%102.25M
9.97%101.89M
12.99%101.23M
Fixed assets
-5.80%440.94M
----
-14.22%434.44M
----
-20.30%468.07M
----
-19.00%506.45M
----
-11.09%587.27M
----
Constru in process
-38.47%21.49M
----
21.04%36.07M
----
48.46%34.93M
----
51.18%29.8M
----
36.64%23.53M
----
Intangible assets
50.39%151.7M
65.24%156.56M
2.69%98.34M
-1.98%99.69M
-1.93%100.87M
-8.89%94.75M
-1.97%95.77M
21.99%101.71M
22.79%102.86M
23.31%104M
Development expenditure
18.77%530.12M
19.27%503M
27.56%530.41M
30.27%469.28M
30.34%446.36M
37.49%421.72M
34.64%415.81M
28.69%360.23M
29.08%342.45M
20.28%306.73M
Long deferred expense
-13.47%30.69M
-13.21%31.84M
-12.79%33.05M
-12.39%34.26M
-12.37%35.47M
15.47%36.68M
14.19%37.89M
13.02%39.1M
12.40%40.48M
41.74%31.77M
Deferred tax assets
-19.06%23.41M
2.81%24.38M
-0.48%25.73M
-13.47%26.05M
-15.07%28.92M
-22.01%23.72M
-9.90%25.85M
1.95%30.1M
19.78%34.05M
11.04%30.41M
Usufruct assets
1.46%9.48M
-11.40%8.97M
-27.58%7.89M
-28.95%8.49M
-20.53%9.34M
-22.84%10.12M
-18.43%10.9M
--11.95M
--11.75M
--13.12M
Other non current assets
79.14%9.41M
189.66%10.72M
227.15%13.2M
15.39%10.8M
30.25%5.25M
-13.78%3.7M
-7.65%4.04M
21.08%9.36M
-26.60%4.03M
-23.57%4.29M
Total non current assets
7.40%1.37B
8.17%1.36B
4.79%1.34B
3.54%1.29B
2.09%1.28B
2.64%1.26B
3.12%1.28B
4.62%1.25B
4.90%1.25B
3.81%1.23B
Total assets
17.85%3.81B
10.27%3.69B
3.21%3.52B
-3.88%3.44B
-12.35%3.23B
-9.11%3.34B
-8.33%3.41B
-2.33%3.58B
3.66%3.69B
-4.17%3.68B
Liabilities
Current liabilities
Short term loan
18.61%70.03M
86.59%84.03M
153.18%114.02M
-3.30%29.01M
--59.04M
--45.03M
--45.03M
--30M
----
----
Notes payable and accounts payable
12.17%38.6M
24.43%45.53M
-2.01%38.29M
17.79%60.22M
-56.63%34.41M
-59.01%36.59M
-40.54%39.08M
-4.23%51.13M
27.31%79.34M
5.17%89.26M
-Notes payable
----
----
----
--30M
----
----
----
----
----
----
-Accounts payable
12.17%38.6M
24.43%45.53M
-2.01%38.29M
-40.89%30.22M
-56.63%34.41M
-59.01%36.59M
-40.54%39.08M
-4.23%51.13M
27.31%79.34M
5.17%89.26M
Contract liabilities
327.35%44.09M
194.82%28.54M
29.95%13.8M
45.12%11.94M
-34.85%10.32M
-30.90%9.68M
-30.39%10.62M
-69.89%8.23M
21.00%15.84M
16.15%14.01M
Advance receipts
297.73%1.42M
77.76%473.14K
95.05%2.08M
--374.21K
--356K
--266.17K
--1.06M
----
----
----
Salaries payable
-28.01%11.3M
-30.70%10.71M
-16.51%34.58M
-19.20%15.15M
4.99%15.7M
-0.35%15.45M
-6.84%41.42M
-33.25%18.75M
-35.96%14.96M
-25.42%15.5M
Taxs payable
17.68%18.72M
8.62%13.94M
-8.28%13.54M
-31.48%21.16M
-58.45%15.91M
-67.76%12.84M
-72.06%14.76M
-37.35%30.88M
-34.39%38.29M
-31.81%39.81M
Other payable (including interest and dividends)
184.40%458.89M
104.45%380.48M
26.12%210.53M
112.22%369.11M
-9.40%161.35M
7.23%186.1M
-23.73%166.93M
-7.18%173.93M
-14.33%178.1M
-49.64%173.55M
-Dividend payable
----
----
----
----
----
----
----
----
--25.65M
----
-Other payable
184.40%458.89M
----
26.12%210.53M
----
5.84%161.35M
----
-23.73%166.93M
----
-26.67%152.44M
----
Non current liabilities due within one year
8.21%3.73M
-0.33%3.56M
-12.31%3.03M
3.21%3.2M
17.30%3.45M
53.03%3.57M
32.44%3.45M
--3.1M
--2.94M
--2.34M
Other current liabilities
518.92%5.68M
194.82%3.71M
21.48%1.68M
45.12%1.55M
-55.40%918.13K
-30.90%1.26M
-30.39%1.38M
-69.89%1.07M
21.00%2.06M
-31.63%1.82M
Total current liabilities
116.44%652.45M
83.72%570.97M
33.30%431.55M
61.38%511.72M
-9.07%301.45M
-7.58%310.78M
-19.41%323.74M
-9.15%317.09M
-9.60%331.52M
-38.11%336.29M
Current liabilities
Deferred tax liabilities
-23.17%9.91M
-18.95%10.18M
-18.95%10.18M
-16.73%12.56M
-12.61%12.9M
-16.73%12.56M
-16.73%12.56M
-4.14%15.08M
-3.60%14.76M
-2.63%15.08M
Long term deferred income
-11.76%62.25M
-5.46%63.73M
15.97%64.72M
30.25%68.6M
16.94%70.54M
-1.31%67.41M
-19.04%55.81M
-23.80%52.67M
-13.78%60.32M
-2.16%68.31M
Lease liabilities
-2.51%7.74M
-21.95%5.92M
-24.27%6.75M
-38.52%5.9M
-19.88%7.94M
-33.54%7.59M
-22.59%8.92M
--9.59M
--9.91M
--11.42M
Total non current liabilities
-12.57%79.9M
-8.83%79.83M
5.65%81.65M
12.56%87.06M
7.52%91.39M
-7.65%87.56M
-19.10%77.29M
-8.85%77.34M
-0.33%85M
11.14%94.81M
Total liabilities
86.43%732.35M
63.38%650.8M
27.97%513.2M
51.81%598.78M
-5.69%392.83M
-7.60%398.34M
-19.35%401.03M
-9.09%394.43M
-7.85%416.52M
-31.43%431.1M
Shareholders equity
Paid-in capital
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
Capital reserve funds
135.27%95.4M
165.50%117.45M
169.95%136.94M
9.83%62.73M
-32.81%40.55M
1,742.59%44.24M
5,294.75%50.73M
3,699.98%57.11M
3,944.22%60.35M
60.89%2.4M
Surplus reserve funds
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
Retained profit
5.45%1.66B
-2.92%1.61B
-8.59%1.58B
-18.14%1.54B
-20.17%1.57B
-19.67%1.66B
-15.56%1.73B
-8.41%1.89B
1.89%1.97B
1.74%2.07B
Other composite income
-43.54%6.57M
-67.61%3.51M
-23.30%4.96M
43.33%16.6M
169.29%11.64M
348.17%10.84M
204.97%6.47M
349.44%11.58M
192.04%4.32M
-8.04%-4.37M
Specific reserves
37.04%2.39M
37.90%2.09M
107.16%1.62M
78.54%1.91M
231.15%1.74M
1,621.08%1.51M
196.54%781.85K
3.07%1.07M
69.21%526.33K
--88.02K
Shareholders equity without minority interests
4.85%2.94B
0.62%2.91B
-2.13%2.9B
-10.56%2.8B
-12.72%2.8B
-10.74%2.89B
-7.94%2.96B
-3.13%3.13B
3.37%3.21B
1.13%3.24B
Minority interests
252.83%141.81M
140.96%124.62M
119.77%110.7M
-22.86%42.72M
-37.30%40.19M
759.16%51.72M
470.78%50.37M
24,301.31%55.38M
2,200.24%64.1M
35.27%6.02M
Total shareholder equity
8.36%3.08B
3.09%3.04B
-0.09%3.01B
-10.77%2.84B
-13.20%2.84B
-9.31%2.94B
-6.64%3.01B
-1.43%3.19B
5.34%3.27B
1.17%3.25B
Total liabilityies and equity
17.85%3.81B
10.27%3.69B
3.21%3.52B
-3.88%3.44B
-12.35%3.23B
-9.11%3.34B
-8.33%3.41B
-2.33%3.58B
3.66%3.69B
-4.17%3.68B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds 57.06%1.03B56.11%1.17B35.50%1.05B-1.27%822.59M-11.13%658.17M-14.20%747.52M-33.70%772.71M-1.55%833.14M-13.28%740.59M5.98%871.26M
Transactional financial assets 10.15%917.81M-5.22%727.62M-14.93%713.83M-1.00%868.41M-8.99%833.24M-6.34%767.66M60.62%839.08M78.01%877.17M64.07%915.58M27.07%819.61M
Notes receivable and accounts receivable 16.59%214.45M-17.55%139.79M-33.76%141.32M-36.86%188.69M-47.35%183.93M-56.11%169.54M-57.04%213.36M-42.43%298.87M-42.14%349.31M-43.35%386.25M
-Notes receivable ------------------------182.95%2.03M----------1.98M
-Accounts receivable 16.59%214.45M-17.55%139.79M-33.13%141.32M-36.86%188.69M-47.35%183.93M-55.88%169.54M-57.38%211.33M-42.43%298.87M-41.68%349.31M-43.64%384.27M
Other receivables (including interest and dividends) -37.31%14.39M-42.17%13.59M97.88%49.88M-38.34%16.47M13.82%22.96M41.77%23.49M54.74%25.21M-73.86%26.71M17.97%20.17M-2.94%16.57M
-Dividend receivable --------233.33%1.56M--------------467.8K------------
-Other receivable -37.31%14.39M----95.32%48.32M----13.82%22.96M----51.87%24.74M----17.97%20.17M----
Advance payment -27.70%9.8M-57.88%20.59M57.15%14.84M-70.45%15.23M-90.10%13.56M-11.45%48.89M-39.55%9.44M-77.78%51.54M198.53%137.01M30.67%55.21M
Inventories 17.57%181.59M7.10%170.05M18.34%167.49M11.36%156.99M-3.45%154.45M13.58%158.78M-0.22%141.53M-4.36%140.98M8.26%159.98M-12.33%139.8M
Receivable financing -13.16%52.87M-45.81%73.62M-63.60%39.92M-34.29%54.54M-38.48%60.88M13.06%135.85M28.66%109.67M-31.30%83M-18.00%98.96M-57.10%120.16M
Other current assets -55.99%11.88M-60.24%13.11M-55.16%12.16M25.94%25.19M87.62%27M-24.10%32.98M-37.69%27.12M70.03%20M-14.78%14.39M356.52%43.45M
Total current assets 24.68%2.44B11.54%2.33B2.26%2.19B-7.86%2.15B-19.78%1.95B-14.99%2.08B-14.03%2.14B-5.70%2.33B3.04%2.44B-7.71%2.45B
Non Current assets
Other equity investment 239.37%13.68M260.23%13.67M259.37%13.69M262.12%13.99M14.24%4.03M9.07%3.79M14.40%3.81M5.22%3.86M-7.97%3.53M-9.89%3.48M
Investment real estate -5.17%39M-5.10%39.53M-5.04%40.06M3,033.67%40.59M3,005.48%41.12M2,978.50%41.65M2,952.64%42.18M-8.18%1.3M-8.02%1.32M-7.86%1.35M
Long-term equity investment -0.80%104.12M-0.30%103.89M0.73%104.52M2.70%105M3.02%104.96M2.93%104.2M1.88%103.76M6.31%102.25M9.97%101.89M12.99%101.23M
Fixed assets -5.80%440.94M-----14.22%434.44M-----20.30%468.07M-----19.00%506.45M-----11.09%587.27M----
Constru in process -38.47%21.49M----21.04%36.07M----48.46%34.93M----51.18%29.8M----36.64%23.53M----
Intangible assets 50.39%151.7M65.24%156.56M2.69%98.34M-1.98%99.69M-1.93%100.87M-8.89%94.75M-1.97%95.77M21.99%101.71M22.79%102.86M23.31%104M
Development expenditure 18.77%530.12M19.27%503M27.56%530.41M30.27%469.28M30.34%446.36M37.49%421.72M34.64%415.81M28.69%360.23M29.08%342.45M20.28%306.73M
Long deferred expense -13.47%30.69M-13.21%31.84M-12.79%33.05M-12.39%34.26M-12.37%35.47M15.47%36.68M14.19%37.89M13.02%39.1M12.40%40.48M41.74%31.77M
Deferred tax assets -19.06%23.41M2.81%24.38M-0.48%25.73M-13.47%26.05M-15.07%28.92M-22.01%23.72M-9.90%25.85M1.95%30.1M19.78%34.05M11.04%30.41M
Usufruct assets 1.46%9.48M-11.40%8.97M-27.58%7.89M-28.95%8.49M-20.53%9.34M-22.84%10.12M-18.43%10.9M--11.95M--11.75M--13.12M
Other non current assets 79.14%9.41M189.66%10.72M227.15%13.2M15.39%10.8M30.25%5.25M-13.78%3.7M-7.65%4.04M21.08%9.36M-26.60%4.03M-23.57%4.29M
Total non current assets 7.40%1.37B8.17%1.36B4.79%1.34B3.54%1.29B2.09%1.28B2.64%1.26B3.12%1.28B4.62%1.25B4.90%1.25B3.81%1.23B
Total assets 17.85%3.81B10.27%3.69B3.21%3.52B-3.88%3.44B-12.35%3.23B-9.11%3.34B-8.33%3.41B-2.33%3.58B3.66%3.69B-4.17%3.68B
Liabilities
Current liabilities
Short term loan 18.61%70.03M86.59%84.03M153.18%114.02M-3.30%29.01M--59.04M--45.03M--45.03M--30M--------
Notes payable and accounts payable 12.17%38.6M24.43%45.53M-2.01%38.29M17.79%60.22M-56.63%34.41M-59.01%36.59M-40.54%39.08M-4.23%51.13M27.31%79.34M5.17%89.26M
-Notes payable --------------30M------------------------
-Accounts payable 12.17%38.6M24.43%45.53M-2.01%38.29M-40.89%30.22M-56.63%34.41M-59.01%36.59M-40.54%39.08M-4.23%51.13M27.31%79.34M5.17%89.26M
Contract liabilities 327.35%44.09M194.82%28.54M29.95%13.8M45.12%11.94M-34.85%10.32M-30.90%9.68M-30.39%10.62M-69.89%8.23M21.00%15.84M16.15%14.01M
Advance receipts 297.73%1.42M77.76%473.14K95.05%2.08M--374.21K--356K--266.17K--1.06M------------
Salaries payable -28.01%11.3M-30.70%10.71M-16.51%34.58M-19.20%15.15M4.99%15.7M-0.35%15.45M-6.84%41.42M-33.25%18.75M-35.96%14.96M-25.42%15.5M
Taxs payable 17.68%18.72M8.62%13.94M-8.28%13.54M-31.48%21.16M-58.45%15.91M-67.76%12.84M-72.06%14.76M-37.35%30.88M-34.39%38.29M-31.81%39.81M
Other payable (including interest and dividends) 184.40%458.89M104.45%380.48M26.12%210.53M112.22%369.11M-9.40%161.35M7.23%186.1M-23.73%166.93M-7.18%173.93M-14.33%178.1M-49.64%173.55M
-Dividend payable ----------------------------------25.65M----
-Other payable 184.40%458.89M----26.12%210.53M----5.84%161.35M-----23.73%166.93M-----26.67%152.44M----
Non current liabilities due within one year 8.21%3.73M-0.33%3.56M-12.31%3.03M3.21%3.2M17.30%3.45M53.03%3.57M32.44%3.45M--3.1M--2.94M--2.34M
Other current liabilities 518.92%5.68M194.82%3.71M21.48%1.68M45.12%1.55M-55.40%918.13K-30.90%1.26M-30.39%1.38M-69.89%1.07M21.00%2.06M-31.63%1.82M
Total current liabilities 116.44%652.45M83.72%570.97M33.30%431.55M61.38%511.72M-9.07%301.45M-7.58%310.78M-19.41%323.74M-9.15%317.09M-9.60%331.52M-38.11%336.29M
Current liabilities
Deferred tax liabilities -23.17%9.91M-18.95%10.18M-18.95%10.18M-16.73%12.56M-12.61%12.9M-16.73%12.56M-16.73%12.56M-4.14%15.08M-3.60%14.76M-2.63%15.08M
Long term deferred income -11.76%62.25M-5.46%63.73M15.97%64.72M30.25%68.6M16.94%70.54M-1.31%67.41M-19.04%55.81M-23.80%52.67M-13.78%60.32M-2.16%68.31M
Lease liabilities -2.51%7.74M-21.95%5.92M-24.27%6.75M-38.52%5.9M-19.88%7.94M-33.54%7.59M-22.59%8.92M--9.59M--9.91M--11.42M
Total non current liabilities -12.57%79.9M-8.83%79.83M5.65%81.65M12.56%87.06M7.52%91.39M-7.65%87.56M-19.10%77.29M-8.85%77.34M-0.33%85M11.14%94.81M
Total liabilities 86.43%732.35M63.38%650.8M27.97%513.2M51.81%598.78M-5.69%392.83M-7.60%398.34M-19.35%401.03M-9.09%394.43M-7.85%416.52M-31.43%431.1M
Shareholders equity
Paid-in capital 0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M
Capital reserve funds 135.27%95.4M165.50%117.45M169.95%136.94M9.83%62.73M-32.81%40.55M1,742.59%44.24M5,294.75%50.73M3,699.98%57.11M3,944.22%60.35M60.89%2.4M
Surplus reserve funds 0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M
Retained profit 5.45%1.66B-2.92%1.61B-8.59%1.58B-18.14%1.54B-20.17%1.57B-19.67%1.66B-15.56%1.73B-8.41%1.89B1.89%1.97B1.74%2.07B
Other composite income -43.54%6.57M-67.61%3.51M-23.30%4.96M43.33%16.6M169.29%11.64M348.17%10.84M204.97%6.47M349.44%11.58M192.04%4.32M-8.04%-4.37M
Specific reserves 37.04%2.39M37.90%2.09M107.16%1.62M78.54%1.91M231.15%1.74M1,621.08%1.51M196.54%781.85K3.07%1.07M69.21%526.33K--88.02K
Shareholders equity without minority interests 4.85%2.94B0.62%2.91B-2.13%2.9B-10.56%2.8B-12.72%2.8B-10.74%2.89B-7.94%2.96B-3.13%3.13B3.37%3.21B1.13%3.24B
Minority interests 252.83%141.81M140.96%124.62M119.77%110.7M-22.86%42.72M-37.30%40.19M759.16%51.72M470.78%50.37M24,301.31%55.38M2,200.24%64.1M35.27%6.02M
Total shareholder equity 8.36%3.08B3.09%3.04B-0.09%3.01B-10.77%2.84B-13.20%2.84B-9.31%2.94B-6.64%3.01B-1.43%3.19B5.34%3.27B1.17%3.25B
Total liabilityies and equity 17.85%3.81B10.27%3.69B3.21%3.52B-3.88%3.44B-12.35%3.23B-9.11%3.34B-8.33%3.41B-2.33%3.58B3.66%3.69B-4.17%3.68B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data